Evaluation of the effect of Modafinil in the improvement of the level of consciousness in patients with COVID‐19 encephalopathy: A randomized controlled trial
Neuropsychopharmacology Reports · 2024-09 · 44 (3) · 490-501
DOI: 10.1002/npr2.12447 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Neuropsychopharmacology Reports, online erschienen am 08.05.2024. Verfasst von Fatemeh Talebi Kiasari und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Hazrat-e Rasool General Hospital, School of Medicine, Iran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Modafinil, COVID-19, Consciousness. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Aim
COVID‐19 can lead to encephalopathy and loss of consciousness. This double‐blinded randomized clinical trial conducted in Tehran, Iran, aimed to assess the potential effectiveness of modafinil in patients with COVID‐19‐related encephalopathy.
Methods
Nineteen non‐intubated COVID‐19 patients with encephalopathy were randomized into two groups: a treatment group receiving crushed modafinil tablets and a placebo group receiving starch powder. Modafinil was administered at a dose of 100 mg every 2 h, reaching a peak dosage of 400 mg. The level of consciousness was assessed using the Glasgow Coma Score (GCS) at multiple time points on the day of medication administration. The trial was registered under IRCT20170903036041N3 on 23/5/2021.
Results
The average age in the modafinil and placebo groups was 75.33 and 70 years, respectively. No significant differences were observed between the two groups in terms of chronic conditions, clinical symptoms, or laboratory data. GCS scores were similar between the groups at baseline ( p ‐value = 0.699). After four doses of modafinil, GCS scores were slightly higher in the treatment group, but this difference was not statistically significant ( p ‐value = 0.581). GCS scores after each round of drug administration didn't significantly differ between the treatment and placebo groups ( p ‐value = 0.908).
Conclusion
Modafinil exhibited a slight improvement in the level of consciousness among COVID‐19 patients with encephalopathy, although this improvement did not reach statistical significance when compared to the control group. Further research with larger sample sizes and longer treatment durations is recommended to explore modafinil's potential benefits in managing altered consciousness in COVID‐19 patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Hazrat-e Rasool General Hospital, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
- School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
- Trauma and Injury Research Center, Critical Care Department, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
- Department of Nutrition, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.
ORCID-Profile: Roya Ghafoury
Zitieren
APA
Talebi Kiasari, F., Naghshbandi, M., Emamikhah, M., Moradi Moghaddam, O., Niakan Lahiji, M., Rohani, M., Yazdi, N., Movahedi, H., Amanollahi, A., Irandoost, P., & Ghafoury, R. (2024). Evaluation of the effect of Modafinil in the improvement of the level of consciousness in patients with COVID‐19 encephalopathy: A randomized controlled trial. Neuropsychopharmacology Reports, 44(3), 490-501. https://doi.org/10.1002/npr2.12447
Vancouver
Talebi Kiasari F, Naghshbandi M, Emamikhah M, Moradi Moghaddam O, Niakan Lahiji M, Rohani M, et al. Evaluation of the effect of Modafinil in the improvement of the level of consciousness in patients with COVID‐19 encephalopathy: A randomized controlled trial. Neuropsychopharmacology Reports. 2024;44(3):490-501. doi:10.1002/npr2.12447
BibTeX
@article{TalebiKiasari2024,
author = {Talebi Kiasari, Fatemeh and Naghshbandi, Mobin and Emamikhah, Maziar and Moradi Moghaddam, Omid and Niakan Lahiji, Mohammad and Rohani, Mohammad and Yazdi, Narges and Movahedi, Hamidreza and Amanollahi, Alireza and Irandoost, Pardis and Ghafoury, Roya},
title = {Evaluation of the effect of Modafinil in the improvement of the level of consciousness in patients with COVID‐19 encephalopathy: A randomized controlled trial},
journal = {Neuropsychopharmacology Reports},
year = {2024},
volume = {44},
number = {3},
pages = {490--501},
doi = {10.1002/npr2.12447}
}
EUVIMED